Avacopan in GPA - non-inferior to prednisone for induction remission - received FDA approval for treatment of severe ac
Tweet Content
Avacopan in GPA
- non-inferior to prednisone for induction remission
- received FDA approval for treatment of severe active GPA in combo with standard therapy and steroids
- should be used in newly diagnosed active or relapsing disease
@rheumnow #RNL2023 https://t.co/My6M5MGBl1 https://t.co/0aPFUeE55Q
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off